🇺🇸 FDA
Patent

US 11073523

Method for differentially diagnosing ACTH-dependent Cushing's syndrome

granted A61KA61K31/4745A61K31/567

Quick answer

US patent 11073523 (Method for differentially diagnosing ACTH-dependent Cushing's syndrome) held by Corcept Therapeutics Incorporated expires Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Corcept Therapeutics Incorporated
Grant date
Tue Jul 27 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4745, A61K31/567, A61K31/573